Abstract
Although research into molecular treatments for DMD is at an exciting stage, the use of corticosteroids and good quality care currently remain a high priority in prolonging survival and increasing quality of life. The benefits of steroids in DMD were first suggested in 1974. However, lack of long-term study and concerns about side effects have led to inconsistency of use, regime and dosage in clinical practise. Patients and families ask for more information to guide practice within different centres and countries.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
